Detrimental Effect of Postoperative Complications on Oncologic Efficacy of R0 Pancreatectomy in Ductal Adenocarcinoma of the Pancreas

被引:27
|
作者
Kang, Chang Moo [1 ,2 ]
Kim, Dong Hyun [1 ,2 ]
Choi, Gi Hong [1 ,2 ]
Kim, Kyung Sik [1 ,2 ]
Choi, Jin Sub [1 ,2 ]
Lee, Woo Jung [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Yonsei Univ Hlth Syst, Inst Gastroenterol, Seoul, South Korea
关键词
Pancreatic cancer; Complication; R0; Pancreatectomy; Survival; LONG-TERM SURVIVAL; SINGLE-INSTITUTION EXPERIENCE; 1423; PANCREATICODUODENECTOMIES; RESECTABLE ADENOCARCINOMA; SURGEONS CONTRIBUTION; CURATIVE RESECTION; CANCER; HEAD; DETERMINANTS; CARCINOMA;
D O I
10.1007/s11605-009-0823-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Margin-negative resection of pancreatic cancers has proven to be the most effective treatment to date. Although there are frequent surgery-related complications following pancreatectomy, the oncologic effect of these complications following pancreatectomy for pancreatic cancer has not been studied. Retrospective observation of medical records of resected pancreatic ductal adenocarcinoma performed from January 1990 to June 2006 was used in this study. Potentially curative surgical resections of pancreatic ductal adenocarcinoma were performed on 103 patients. Survival was analyzed according to various clinicopathologic variables. Negative surgical margins (p = 0.0075) and absence of postoperative major complications related to surgery (p = 0.0116) were all significantly favorable prognostic factors in both univariate and multivariate analysis. Margin-negative pancreatectomy without major complications showed the most favorable oncologic outcomes in resected pancreatic cancer (median survival, 35.6 months; 95% confidential interval, 25.8-45.4 months), while major morbidities diminished survival benefit of R0 resection [R0-Cx(+), Exp(beta) = 1.925, p = 0.034, and R1, Exp(beta) = 3.129, p = 0.001]. Surgery-related major complication diminished the oncologic efficacy of R0 pancreatectomy. Margin-negative resection without major complication can enhance postoperative oncologic outcomes in ductal adenocarcinoma of the pancreas.
引用
收藏
页码:907 / 914
页数:8
相关论文
共 34 条
  • [1] Detrimental Effect of Postoperative Complications on Oncologic Efficacy of R0 Pancreatectomy in Ductal Adenocarcinoma of the Pancreas
    Chang Moo Kang
    Dong Hyun Kim
    Gi Hong Choi
    Kyung Sik Kim
    Jin Sub Choi
    Woo Jung Lee
    Journal of Gastrointestinal Surgery, 2009, 13
  • [2] R Classification and Pancreatic Ductal Adenocarcinoma-R0 is R0
    Munding, J.
    Uhl, W.
    Tannapfel, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (10): : 1423 - 1427
  • [3] Neighborhood Disadvantage and Postoperative Complications After Pancreatectomy for Pancreatic Ductal Adenocarcinoma
    Marcinak, Clayton T.
    Vidri, Roberto J.
    Praska, Corinne E.
    Mathew, Jomol
    Churpek, Matthew M.
    Afshar, Majid
    Weber, Sharon M.
    Varley, Patrick R.
    Abbott, Daniel E.
    LoConte, Noelle K.
    Zafar, Syed Nabeel
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S172 - S173
  • [4] Impact of Lymph Node Involvement on Long-term Survival after R0 Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas
    Thomas Zacharias
    Daniel Jaeck
    Elie Oussoultzoglou
    Agnes Neuville
    Philippe Bachellier
    Journal of Gastrointestinal Surgery, 2007, 11 : 350 - 356
  • [5] Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas
    Zacharias, Thomas
    Jaeck, Daniel
    Oussoultzoglou, Elie
    Neuville, Agnes
    Bachellier, Philippe
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (03) : 350 - 356
  • [6] COMPARISON OF EFFICACY BETWEEN ADJUVANT CHEMOTHERAPY AND CHEMORADIATION THERAPY AFTER R0 RESECTION FOR PANCREATIC DUCTAL ADENOCARCINOMA
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Shin, Bang-sup
    Huh, Gunn
    Chun, Jung Won
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S322 - S322
  • [7] Effect of sarcopenia on postoperative complications after curative pancreatectomy for adenocarcinoma
    Mercan, Umit
    Ersen, Ogun
    Unal, Ali Ekrem
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2020, 6 (02): : 73 - 77
  • [8] Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma
    Ikenaga, Naoki
    Nakata, Kohei
    Abe, Toshiya
    Watanabe, Yusuke
    Ideno, Noboru
    Murakami, Masatoshi
    Ueda, Keijiro
    Fujimori, Nao
    Fujita, Nobuhiro
    Ishigami, Kousei
    Ogawa, Yoshihiro
    Nakamura, Masafumi
    SURGERY, 2025, 178
  • [9] Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Khachfe, Hussein H.
    Hammad, Abdulrahman Y.
    AlMasri, Samer
    Nassour, Ibrahim
    ElAsmar, Rudy
    Liu, Hao
    de Silva, Annissa
    Kraftician, Jasmine
    Lee, Kenneth K.
    Zureikat, Amer H.
    Paniccia, Alessandro
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (06) : 1097 - 1105
  • [10] Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection
    Kleive, Dyre
    Labori, Knut J.
    Line, Pal-Dag
    Gladhaug, Ivar P.
    Verbeke, Caroline S.
    HPB, 2020, 22 (01) : 50 - 57